Related Experiment Video
Updated: Apr 19, 2026

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
Published on: January 12, 2017
Noninvasive approaches for detecting and monitoring bladder cancer
Sarmistha Talukdar1, Luni Emdad, Swadesh K Das
1Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, USA.
Abstract:
Bladder cancer is the second most common cancer of the urinary tract. Despite existing multiapproach treatment strategies, including radical cystectomy, bladder-sparing therapy with transurethral resection, chemotherapy and radiotherapy, patients with deeply invasive bladder cancers display poor prognosis, with a survival rate of only 30-50%. This can be avoided through proper surveillance and monitoring. Several genetic factors contribute to the progression of bladder cancer, and these molecules serve as cancer biomarkers. Blood, plasma, serum and urine are commonly analyzed for the presence of biomarkers, which can be both nuclear as well as mitochondrial in nature. This review discusses the efficacy of such biomarkers as well as highlights some potential prognostic markers in the field of noninvasive bladder cancer detection.
Insights
Early detection of bladder cancer through genetic biomarkers in blood or urine can improve patient survival rates. This review explores noninvasive methods for monitoring bladder cancer progression and prognosis.
Area of Science:
- Oncology
- Urology
- Genetics
Background:
- Bladder cancer is a prevalent urinary tract malignancy.
- Deeply invasive bladder cancers have a poor prognosis (30-50% survival).
- Current treatments include surgery, chemotherapy, and radiotherapy.
Purpose of the Study:
- To review the efficacy of genetic biomarkers for bladder cancer detection.
- To highlight potential prognostic markers for noninvasive monitoring.
- To discuss the role of biomarkers in improving patient outcomes.
Main Methods:
- Literature review of studies on bladder cancer biomarkers.
- Analysis of nuclear and mitochondrial biomarkers.
- Evaluation of biomarkers in blood, plasma, serum, and urine samples.
Main Results:
- Genetic factors significantly contribute to bladder cancer progression.
- Biomarkers found in bodily fluids offer potential for early detection.
- Several molecules show promise as prognostic indicators.
Conclusions:
- Noninvasive detection of bladder cancer through biomarkers is crucial.
- Biomarker analysis can aid in surveillance and monitoring.
- Further research into prognostic markers can improve bladder cancer management.
Related Concept Videos
Imaging Studies VI: Voiding Cystourethrography and Cystography
Imaging Studies II: Ultrasonography
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Nursing Assessment of the Genitourinary System III: Percussion and Auscultation
Imaging Studies IV: Magnetic Resonance Imaging

